Paxton M B
American Petroleum Institute, Washington, DC 20005, USA. paxton@.api.org
Environ Health Perspect. 1996 Dec;104 Suppl 6(Suppl 6):1431-6. doi: 10.1289/ehp.961041431.
A reanalysis of the Pliofilm cohort was conducted incorporating six additional years of follow-up information gathered by the National Institute of Occupational Safety and Health (NIOSH) and a new set of exposure estimates developed recently. The distribution of individual worker exposures calculated with the Paustenbach exposure estimates was compared to those derived using two earlier sets of job-, plant-, and year-specific exposure estimates. A traditional standardized mortality ratio analysis and the Cox proportional hazards model were used to investigate the impact of these exposure estimates and the NIOSH updated information on evaluation of benzene's leukemogenicity. There were no additional cases of multiple myeloma or any indication of increased incidences of solid tumors. The data added in the update did not greatly modify the estimated relative risk of all leukemias associated with benzene exposure but confirmed previous findings that occupational exposure only to very high concentrations had leukemogenic potential. Leukemia has not been observed in anyone who began employment in Pliofilm production after 1950. Neither the Paustenbach nor the Crump exposures gave dose-response estimates as steep as that resulting from the Rinsky exposures.
对普利菲姆队列进行了重新分析,纳入了美国国家职业安全与健康研究所(NIOSH)收集的另外六年随访信息以及最近制定的一组新的暴露估计值。将使用保斯滕巴赫暴露估计值计算的个体工人暴露分布与使用两组早期特定工作、工厂和年份的暴露估计值得出的分布进行了比较。采用传统的标准化死亡比分析和Cox比例风险模型来研究这些暴露估计值和NIOSH更新信息对评估苯致白血病性的影响。没有新增多发性骨髓瘤病例,也没有实体瘤发病率增加的迹象。更新中添加的数据并没有极大地改变与苯暴露相关的所有白血病的估计相对风险,但证实了先前的发现,即仅职业暴露于非常高的浓度才有致癌潜力。1950年后开始在普利菲姆生产中工作的人中未观察到白血病。保斯滕巴赫和克伦普的暴露剂量反应估计都不如林斯基暴露得出的那样陡峭。